Study Participant Demographics and Characteristics
| Noncompleters (n = 132) | Completers (n = 259) | P Value | |
|---|---|---|---|
| Age (years), mean | 41.6 | 44.6 | .06 |
| Sex | |||
| Female | 53 (40.2) | 122 (47.1) | .19 |
| Male | 79 (59.9) | 137 (52.9) | |
| Treatment regimen | |||
| Isoniazid and rifapentine | 13 (9.9) | 74 (28.6) | <.001 |
| Rifampin alone | 12 (9.1) | 70 (27.0) | |
| Isoniazid alone | 107 (81.1) | 115 (44.4) | |
| Type of insurance* | |||
| Private | 10 (8.7) | 49 (23.3) | <.001 |
| Medicare/Medicaid/funded by government | 30 (26.1) | 45 (21.4) | |
| Charity/no insurance | 55 (47.8) | 107 (51.0) | |
| Other | 20 (17.4) | 9 (4.3) | |
| Race | |||
| White | 11 (9.1) | 18 (7.1) | .10 |
| Black | 39 (32.2) | 55 (21.6) | |
| Asian | 46 (38.0) | 115 (45.1) | |
| Mexican/other Hispanic | 16 (13.2) | 32 (12.6) | |
| Pacific Islander | 5 (4.1) | 27 (10.6) | |
| Other | 4 (3.3) | 8 (3.1) | |
| Foreign born | 110 (90.2) | 230 (91.3) | .73 |
| English speaking | 66 (50.8) | 136 (53.3) | .63 |
| Marital status† | |||
| Married | 48 (60.8) | 115 (73.7) | .04 |
| Unmarried/separated | 31 (39.2) | 41 (26.3) | |
| Homeless‡ | 18 (15.0) | 26 (10.7) | .24 |
| Experienced side effects | 37 (28.0) | 94 (36.3) | .10 |
| Medical problems (n) | |||
| 0 | 47 (35.6) | 130 (50.2) | .01 |
| 1–2 | 42 (31.8) | 77 (29.7) | |
| ≥3 | 43 (32.6) | 52 (20.1) | |
| Medications (n) | |||
| 0–1 | 45 (34.1) | 93 (35.9) | .86 |
| 2–3 | 49 (37.1) | 89 (34.4) | |
| ≥3 | 38 (28.8) | 77 (29.7) | |
| Tobacco use | 23 (17.4) | 26 (10.0) | .04 |
| Alcohol use (>3 drinks, abuse, or dependence) | 25 (18.9) | 27 (10.4) | .02 |